People · Operator
Named in public records as an officer, director or promoter · active 2015–2019 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mateon Therapeutics Inc | — | Biotechnology | Series B | $45.3M | $1.1M | 2019 |
| Stocosil Inc. | — | Pharmaceuticals | Pre-Seed | $3.0M | $26.8M | 2015 |
| OncoTelic Inc. | — | Pharmaceuticals | Pre-Seed | $300K | $14.2M | 2015 |
Chulho Park at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chulho Park on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Vuong Trieu | 3 | 5 |
| Amit Shah | 1 | 10 |
| Bobby W. Sandage, Jr. | 1 | 5 |
| Anthony Maida | 1 | 5 |
| Pyng Soon | 1 | 2 |
| James B. Murphy | 1 | 2 |
| William Schwieterman | 1 | 2 |
| Matthew M. Loar | 1 | 2 |
| Donald R. Reynolds | 1 | 2 |
| Chao Hsiao | 1 | 2 |
| Larn Hwang | 1 | 1 |
| Alastair J.J. Wood | 1 | 1 |
| David J.J. Chaplin | 1 | 1 |
| Saran Saund | 1 | 1 |
| Seymour Fein | 1 | 1 |
| Chuho Park | 1 | 1 |
| Fatih Uckun | 1 | 1 |
| Matthew Loar | 1 | 1 |
| Simon C. Pedder | 1 | 1 |
| David J. Chaplin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.